News Coverage - Parker Institute for Cancer Immunotherapy

Research
Network
News
About
Donate

Research
Network
- Research Institutions
  Our academic collaborators’ seminal contributions push the field forward
- Directory
  Our constellation of renowned thinkers and partners
- Strategic Partnerships
  The right collaborators across pharma, biotech and nonprofit
- Early Career Researcher Awards
  The next generation of scientific leaders in cancer immunotherapy
News
- News Menu
  - The Latest
    Stories & Announcements
  - News Coverage
    PICI in the News
  - Podcast
    From Bench to Fireside
  - For Media
    Resources for Press
About
- Mission & Vision
  Develop breakthrough immune therapies to turn all cancers into curable diseases faster
- Leadership & Staff
  The driving force behind PICI’s research and operations
- Careers
  Join us. Change lives.
Donate

New England Journal of Medicine

07.12.18

A Parallel Universe of Clinical Trials

Read

The Washington Post

07.11.18

With new genes and an electric shock, scientists turn immune cells against cancer

Read

New York Times

07.11.18

Swift Gene-Editing Method May Revolutionize Treatments for Cancer and Infectious Diseases

Read

Bloomberg

07.11.18

Removing the Hidden Obstacle Holding Back New Cancer Therapies

Read

Healio

06.27.18

CD40 may be key to activating immune response in pancreatic cancer

Read

ASCO Post

06.06.18

For James Allison, PhD, Perseverance and Hard Science Are Paramount in Cancer Research

Read

Endpoint News

06.06.18

Neoantigen pioneer Neon Therapeutics casts off in search of $115M IPO to fuel the race to a personalized cancer treatment

Read

Xconomy

05.31.18

IDO Don’ts: After Immunotherapy Failure, Experts Say Slow Down

Read

Oncology Times

05.31.18

Trust Your Gut: The Microbiome & Metastatic Melanoma

Read

Nature

05.25.18

How gut microbes are joining the fight against cancer

Read

New York Times

05.24.18

Using Medicine and Science to Improve the Quality of Life

Read

Healio

04.18.18

Neoadjuvant pembrolizumab appears effective for resectable melanoma

Read